View Clinical Trial (Medical Research Study)

Safety and Efficacy of Three Formulations of AGN 210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution - NCT01001195-(Clinical Trial 379134)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Rochester
State:  
NY
Zip Code:
Conditions: Primary Open-Angle Glaucoma
Purpose: This study will evaluate the safety, efficacy and dose-response of AGN-210669. This study will also compare AGN-210669 with bimatoprost ophthalmic solution (LUMIGAN®).
Study summary:
Criteria: Inclusion Criteria: - Ocular hypertension or primary open-angle glaucoma in each eye - Patient requires IOP lowering medication in each eye Exclusion Criteria: - Ocular hyperemia or other ocular surface findings in either eye - Active ocular disease - Current or anticipated use of any topical ocular medication (including artificial tears) during the study - Intraocular surgery within past six months or unilateral cataract surgery. - Functionally significant visual field loss - Anticipated wearing of contact lenses during study - Use of other medications that affect IOP such as glaucoma treating medications, within 2 months of screening visit
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: September 9, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.